JPRN-jRCT2080224187已完成1 期
A repeatedly applied study of BBI-4000 in patients with primary hyperhidrosis
KAKEN PHARMACEUTICAL, CO., LTD.0 个研究点目标入组 25 人开始时间: 2018年12月13日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 65age old（—）
- 性别
- All
入选标准
- •Patients diagnosed as primary axillary hyperhidrosis
排除标准
- •Secondary hyperhidrosis
研究者
相似试验
已完成
1 期
Clinical pharmacology study of BBI608JPRN-jRCT2080225351Sumitomo Dainippon Pharma. Co,.Ltd.70
未知
1 期
A Phase I Clinical Study of BBI608 Administered with Paclitaxel in Patients with Previously treated Unresectable/Recurrent Gastric CancerJPRN-jRCT2080222370Sumitomo Dainippon Pharma Co., Ltd.6
未知
1 期
A Phase I Clinical Study of BBI608 in Adult Patients with Advanced Solid TumorsAdvanced solid tumorsJPRN-jRCT2080222106Sumitomo Dainippon Pharma Co., Ltd.18
已完成
1 期
A pharmacokinetic study of BBI-4000 gel in patients with primary focal hyperhidrosis in JapaPrimary focal hyperhidrosisJPRN-jRCT2071210041Yonemura Takuma24
尚未招募
4 期
se of BBCR Homoeopathic Repertory in treatment of EczemaCTRI/2024/05/067867R.B.T.S. Govt. Homoeopathic Medical College and Hospital